8-KMaterial AgreementsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Material Agreement (Sep 20, 2006)

Filed September 20, 2006For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) filed an 8-K report on September 20, 2006, primarily to disclose an amendment to its Receivables Purchase Agreement. The Eighth Amendment to the Receivables Purchase Agreement was dated September 19, 2006. This filing indicates a routine update or modification to the company's financing arrangements related to its receivables. While the filing itself is brief and does not contain detailed financial results or strategic announcements, investors should note that changes to such agreements can impact the company's liquidity and access to capital. The specific terms and implications of this amendment are not detailed in the 8-K, suggesting it may be a standard procedural update. Investors seeking more granular detail would need to review the actual amendment document if it were publicly filed or disclosed elsewhere.

Key Highlights

  • 1Disclosure of the Eighth Amendment to the Receivables Purchase Agreement.
  • 2Amendment dated September 19, 2006.
  • 3Filing submitted on September 20, 2006.
  • 4Indicates a modification to the company's financing structure related to receivables.
  • 5No material financial results or strategic changes were announced in this 8-K.
  • 6The filing is primarily an exhibit disclosure, not a comprehensive update.

Frequently Asked Questions

The main purpose of this 8-K filing is to report the Eighth Amendment to Edwards Lifesciences' Receivables Purchase Agreement, dated September 19, 2006. This is a routine disclosure of a modification to a financing agreement.

No, this specific 8-K filing does not provide new financial results or major strategic updates. It is solely focused on the amendment of a financing agreement.

A Receivables Purchase Agreement is a financing arrangement where a company sells its accounts receivable to a third party (a "purchaser") in exchange for immediate cash. This is a way to raise capital by monetizing outstanding invoices.

Amendments to a Receivables Purchase Agreement can affect a company's liquidity, borrowing costs, or covenants related to its financing. While this filing doesn't detail the specifics, changes in such agreements are important for understanding the company's financial flexibility and capital structure.